NCT04751331View on ClinicalTrials.gov

Neural Response to Inflammatory Challenge in Major Depressive Disorder

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

May 15, 2021

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2027

Conditions
Major Depressive Disorder
Interventions
BIOLOGICAL

LPS

Lipopolysaccharide (LPS) (0.8ng/kg of body weight; E. coli group O:113)

BIOLOGICAL

Saline

0.9% saline administered as an intravenous bolus

Trial Locations (1)

74136

RECRUITING

Laureate Institute for Brain Research, Tulsa

Sponsors
All Listed Sponsors
lead

Laureate Institute for Brain Research, Inc.

OTHER